ROM1 (PF3D7_1114100) is a rhomboid intramembrane serine protease of Plasmodium that participates in the parasite's invasive life-cycle stages through transmembrane-domain cleavage of adhesins and through a stage-specific role in intracellular development (PMID:17040128, PMID:21909259). In a heterologous cleavage assay ROM1 displays a broad substrate range distinct from PfROM4 — it is the only PfROM able to cleave AMA1 and also cleaves TRAP, CTRP, MTRAP, EBA-175, BAEBL, JESEBL, MAEBL, Rh1, Rh2a, Rh2b and Rh4 but not PTRAMP, with cleavage determined by the substrate transmembrane domain, since swapping TMDs between BAEBL and AMA1 switches the relative preferences of ROM1 and PfROM4 (PMID:17040128). In P. falciparum merozoites ROM1 localizes to a distinct thread-like secretory organelle, the mononeme, and redistributes to the apical and posterior poles upon merozoite release (PMID:18048320). Genetic dissection in rodent malaria models establishes that ROM1 is non-essential yet functionally important: in P. yoelii it is required for proper parasitophorous vacuole formation during hepatic-stage development, with ~50% of null parasites forming aberrant PVs and failing to develop, while remaining dispensable for mosquito-stage development (PMID:21909259); in P. berghei ROM1 deletion is viable, attenuates the infection and delays blood-stage patency after liver infection (PMID:19148267, PMID:23490234). Reports diverge on blood-stage virulence of P. berghei ROM1-null parasites: one study found immune clearance and loss of lethality (PMID:19148267), whereas a systematic deletion panel found growth and virulence similar to wild-type (PMID:23490234).